drugset / Trial / NCT02247687
Management of Participants With Low-level Persistent Viremia (ANRS 161 L-VIR)
RandomizedParallel-groupOpen-labelTreatment
Summary
Management of participants with low-level persistent viremia
Timeline
- Start
- 2014-12
- Primary completion
- 2015-09
- Completion
- 2015-09
Outcome
Outcome not reported
Stopped (Enrollment): “Low recruitment of participants for the study”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Darunavir | Small molecule | 600 mg | — |
| Comparator | Raltegravir | Other / unclassified | 400 mg | — |
| Comparator | Ritonavir | Other / unclassified | 100 mg | — |